[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f7KDZKyzlDx9RF-a0NOzVQBkc4DaTD-EIyUjnGy3PgqY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":31,"phaseBuckets":42,"rows":49},"Chelsea and Westminster NHS Foundation Trust",[4],54,false,7,3,14599,44,[13,16,18,20,23,25,27,29],{"name":14,"count":15},"Human Immunodeficiency Virus",4,{"name":17,"count":9},"Coronavirus",{"name":19,"count":9},"Burns",{"name":21,"count":22},"Anxiety",2,{"name":24,"count":22},"Depression",{"name":26,"count":22},"HIV-1-infection",{"name":28,"count":22},"Corona Virus Infection",{"name":30,"count":22},"COVID-19",[32,37],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT04892654","Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch","2026-11-30","Doravirine",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT05177510","Mifepristone Outpatient Labour Induction","2026-12-31","Mifepristone",[43,44,45,46,47,48],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[50,86,115,136,169,195,213,238,264,282],{"intervention":36,"totalTrials":22,"cells":51},{"EARLY_PHASE1":52,"PHASE1":55,"PHASE2":68,"PHASE3":70,"PHASE4":82,"NA":84},{"trials":53,"activeCount":54},[],0,{"trials":56,"activeCount":54},[57],{"nctId":58,"briefTitle":59,"status":60,"phases":61,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":66,"interventions":67},"NCT03894124","Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers","COMPLETED",[44],"2019-07-25","2019-08-06","2019-06-12",24,[14],[36],{"trials":69,"activeCount":54},[],{"trials":71,"activeCount":81,"soonestReadout":35},[72],{"nctId":33,"briefTitle":34,"status":73,"phases":74,"primaryCompletion":35,"completion":75,"start":76,"enrollment":77,"conditions":78,"interventions":79},"RECRUITING",[46],"2027-11-30","2022-08-17",150,[26],[36,80],"Dolutegravir",1,{"trials":83,"activeCount":54},[],{"trials":85,"activeCount":54},[],{"intervention":80,"totalTrials":22,"cells":87},{"EARLY_PHASE1":88,"PHASE1":90,"PHASE2":103,"PHASE3":105,"PHASE4":111,"NA":113},{"trials":89,"activeCount":54},[],{"trials":91,"activeCount":54},[92],{"nctId":93,"briefTitle":94,"status":60,"phases":95,"primaryCompletion":96,"completion":97,"start":98,"enrollment":99,"conditions":100,"interventions":102},"NCT04771754","The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers",[44],"2023-12-31","2024-01-10","2022-03-20",16,[101],"HIV-1-infection on Healthy Volunteers",[80],{"trials":104,"activeCount":54},[],{"trials":106,"activeCount":81,"soonestReadout":35},[107],{"nctId":33,"briefTitle":34,"status":73,"phases":108,"primaryCompletion":35,"completion":75,"start":76,"enrollment":77,"conditions":109,"interventions":110},[46],[26],[36,80],{"trials":112,"activeCount":54},[],{"trials":114,"activeCount":54},[],{"intervention":41,"totalTrials":81,"cells":116},{"EARLY_PHASE1":117,"PHASE1":119,"PHASE2":121,"PHASE3":130,"PHASE4":132,"NA":134},{"trials":118,"activeCount":54},[],{"trials":120,"activeCount":54},[],{"trials":122,"activeCount":81,"soonestReadout":40},[123],{"nctId":38,"briefTitle":39,"status":73,"phases":124,"primaryCompletion":40,"completion":40,"start":125,"enrollment":126,"conditions":127,"interventions":129},[45],"2023-08-25",400,[128],"Labor, Induced",[41],{"trials":131,"activeCount":54},[],{"trials":133,"activeCount":54},[],{"trials":135,"activeCount":54},[],{"intervention":137,"totalTrials":22,"cells":138},"BIKTARVY 50Mg-200Mg-25Mg",{"EARLY_PHASE1":139,"PHASE1":141,"PHASE2":152,"PHASE3":154,"PHASE4":156,"NA":167},{"trials":140,"activeCount":54},[],{"trials":142,"activeCount":54},[143],{"nctId":144,"briefTitle":145,"status":60,"phases":146,"primaryCompletion":147,"completion":147,"start":148,"enrollment":149,"conditions":150,"interventions":151},"NCT04950530","The Effect of Biktarvy (B\u002FF\u002FTAF) on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers",[44],"2024-02-29","2022-12-22",25,[26],[137],{"trials":153,"activeCount":54},[],{"trials":155,"activeCount":54},[],{"trials":157,"activeCount":54},[158],{"nctId":159,"briefTitle":160,"status":161,"phases":162,"primaryCompletion":163,"completion":163,"start":164,"enrollment":81,"conditions":165,"interventions":166},"NCT04944654","Efficacy, Tolerability and Acceptability of Biktarvy by TPLWH","TERMINATED",[47],"2023-05-11","2023-01-07",[14],[137],{"trials":168,"activeCount":54},[],{"intervention":170,"totalTrials":81,"cells":171},"hydrocortisone",{"EARLY_PHASE1":172,"PHASE1":174,"PHASE2":176,"PHASE3":178,"PHASE4":180,"NA":193},{"trials":173,"activeCount":54},[],{"trials":175,"activeCount":54},[],{"trials":177,"activeCount":54},[],{"trials":179,"activeCount":54},[],{"trials":181,"activeCount":54},[182],{"nctId":183,"briefTitle":184,"status":185,"phases":186,"primaryCompletion":187,"completion":187,"start":188,"enrollment":54,"conditions":189,"interventions":191},"NCT00933023","Mild Versus Potent Corticosteroids as Treatment for Phimosis in Children","WITHDRAWN",[47],"2009-09","2009-08",[190],"Phimosis",[170,192],"Betamethasone",{"trials":194,"activeCount":54},[],{"intervention":192,"totalTrials":81,"cells":196},{"EARLY_PHASE1":197,"PHASE1":199,"PHASE2":201,"PHASE3":203,"PHASE4":205,"NA":211},{"trials":198,"activeCount":54},[],{"trials":200,"activeCount":54},[],{"trials":202,"activeCount":54},[],{"trials":204,"activeCount":54},[],{"trials":206,"activeCount":54},[207],{"nctId":183,"briefTitle":184,"status":185,"phases":208,"primaryCompletion":187,"completion":187,"start":188,"enrollment":54,"conditions":209,"interventions":210},[47],[190],[170,192],{"trials":212,"activeCount":54},[],{"intervention":214,"totalTrials":81,"cells":215},"DELSTRIGO 100Mg-300Mg-300Mg",{"EARLY_PHASE1":216,"PHASE1":218,"PHASE2":220,"PHASE3":222,"PHASE4":224,"NA":236},{"trials":217,"activeCount":54},[],{"trials":219,"activeCount":54},[],{"trials":221,"activeCount":54},[],{"trials":223,"activeCount":54},[],{"trials":225,"activeCount":54},[226],{"nctId":227,"briefTitle":228,"status":161,"phases":229,"primaryCompletion":230,"completion":230,"start":231,"enrollment":232,"conditions":233,"interventions":235},"NCT05289986","The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients",[47],"2024-11-21","2023-11-21",19,[234],"Hiv",[214],{"trials":237,"activeCount":54},[],{"intervention":239,"totalTrials":81,"cells":240},"Biktarvy",{"EARLY_PHASE1":241,"PHASE1":243,"PHASE2":245,"PHASE3":247,"PHASE4":260,"NA":262},{"trials":242,"activeCount":54},[],{"trials":244,"activeCount":54},[],{"trials":246,"activeCount":54},[],{"trials":248,"activeCount":54},[249],{"nctId":250,"briefTitle":251,"status":60,"phases":252,"primaryCompletion":253,"completion":254,"start":255,"enrollment":256,"conditions":257,"interventions":258},"NCT04653194","Efficacy of BIC\u002FF\u002FTAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'",[46],"2023-07-30","2023-07-31","2020-09-30",36,[14],[239,259],"Symtuza",{"trials":261,"activeCount":54},[],{"trials":263,"activeCount":54},[],{"intervention":259,"totalTrials":81,"cells":265},{"EARLY_PHASE1":266,"PHASE1":268,"PHASE2":270,"PHASE3":272,"PHASE4":278,"NA":280},{"trials":267,"activeCount":54},[],{"trials":269,"activeCount":54},[],{"trials":271,"activeCount":54},[],{"trials":273,"activeCount":54},[274],{"nctId":250,"briefTitle":251,"status":60,"phases":275,"primaryCompletion":253,"completion":254,"start":255,"enrollment":256,"conditions":276,"interventions":277},[46],[14],[239,259],{"trials":279,"activeCount":54},[],{"trials":281,"activeCount":54},[],{"intervention":283,"totalTrials":81,"cells":284},"Favipiravir",{"EARLY_PHASE1":285,"PHASE1":287,"PHASE2":289,"PHASE3":291,"PHASE4":303,"NA":305},{"trials":286,"activeCount":54},[],{"trials":288,"activeCount":54},[],{"trials":290,"activeCount":54},[],{"trials":292,"activeCount":54},[293],{"nctId":294,"briefTitle":295,"status":60,"phases":296,"primaryCompletion":297,"completion":297,"start":298,"enrollment":299,"conditions":300,"interventions":302},"NCT04373733","Early Intervention in COVID-19: Favipiravir Verses Standard Care",[46],"2021-06-25","2020-05-01",502,[301],"Coronavirus Infection",[283],{"trials":304,"activeCount":54},[],{"trials":306,"activeCount":54},[]]